Home  »  Top Picks   »  CASI Pharmaceuticals Inc. (CASI) latest performanc...

CASI Pharmaceuticals Inc. (CASI) latest performance of -0.69% is not what was on cards

As on May 17, 2021, CASI Pharmaceuticals Inc. (NASDAQ: CASI) started slowly as it slid -0.69% to $1.44. During the day, the stock rose to $1.49 and sunk to $1.40 before settling in for the price of $1.45 at the close. Taking a more long-term approach, CASI posted a 52-week range of $1.32-$3.90.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

It was noted that the giant of the Healthcare sector posted annual sales growth of 216.50% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -14.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.90%. This publicly-traded company’s shares outstanding now amounts to $124.04 million, simultaneously with a float of $80.59 million. The organization now has a market capitalization sitting at $197.14 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9455, while the 200-day Moving Average is $2.2070.

It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 118 workers. It has generated 104,174 per worker during the last fiscal year. Meanwhile, its income per employee was -335,326. The stock had 5.05 Receivables turnover and 0.13 Total Asset turnover. For the Profitability, stocks gross margin was +27.30, operating margin was -223.01 and Pretax Margin of -316.72.

CASI Pharmaceuticals Inc. (CASI) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. CASI Pharmaceuticals Inc.’s current insider ownership accounts for 3.40%, in contrast to 30.20% institutional ownership. According to the most recent insider trade that took place on Mar 26, this organization’s Chairman and CEO bought 3,000,000 shares at the rate of 2.05, making the entire transaction reach 6,150,000 in total value, affecting insider ownership by 3,000,000. Preceding that transaction, on Dec 17, Company’s Chief Financial Officer bought 4,000 for 2.63, making the whole transaction’s value amount to 10,537. This particular insider is now the holder of 10,000 in total.

CASI Pharmaceuticals Inc. (CASI) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 12/30/2020, the company posted -$0.12 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.07) by -$0.05. This company achieved a net margin of -321.89 while generating a return on equity of -62.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.

CASI Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 8.90% and is forecasted to reach -0.29 in the upcoming year.

CASI Pharmaceuticals Inc. (NASDAQ: CASI) Trading Performance Indicators

Let’s observe the current performance indicators for CASI Pharmaceuticals Inc. (CASI). It’s Quick Ratio in the last reported quarter now stands at 9.10. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 13.06.

In the same vein, CASI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.43, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.29 at the market close of one year from today.

Technical Analysis of CASI Pharmaceuticals Inc. (CASI)

Through scrutinizing the latest numbers posted by the [CASI Pharmaceuticals Inc., CASI], it can be observed that its last 5-days Average volume of 1.5 million was better the volume of 1.45 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 26.49% While, its Average True Range was 0.1244.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of CASI Pharmaceuticals Inc. (CASI) in the period of the previous 100 days is set at 4.65%, which indicates a major fall in contrast to 17.91% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 71.60% that was lower than 75.96% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam